Inflammation and diabetic kidney disease: Why mitochondria matter
Diabetes mellitus refers to a group of chronic conditions that affect the body’s ability to effectively use sugar, specifically glucose, resulting in a buildup of sugar in the blood. In 2022, the Centers for Disease Control and Prevention estimated that 11.3% of the U.S. population was diabetic and that 38% of adults over age 18 and 49% of adults over 65 were prediabetic, meaning they had higher-than-normal blood glucose levels.
![Komuraiah Myakala](/getmedia/35a3d5e0-d7a2-4cce-8d10-13df5f3f0921/Myakala-Komuraiah-480x459.jpg?width=300&height=286)
The long-term health effects of diabetes mellitus can be grim. In addition to deteriorating vision, nerve damage and hearing impairment over time, diabetes can also affect larger organ systems. In the U.S., it is the predominant risk factor for cardiovascular and kidney diseases. Diabetics are at increased risk for hypertension, heart attack and stroke; furthermore, one in three diabetic adults have diabetic kidney disease, or DKD.
In DKD, prolonged elevated glucose in the blood damages blood vessels and nephrons, the cells in the kidney responsible for filtration. Often occurring in parallel with ailments such as high blood pressure, DKD damages kidneys increasingly over time. A recent study in the Journal of Biological Chemistry demonstrated a potential to mitigate this damage by improving the function of mitochondria, a cellular organelle responsible for maintaining and generating energy.
Komuraiah Myakala, a research instructor at Georgetown University, uses animal models that mimic Type 2 diabetic disease progression, known as db/db mice, when testing his hypotheses for DKD.
“We have to pick the right model to understand the disease,” Myakala said. “Every metabolic disease is regulated by different signaling pathways; we need to understand, if there is, a causal relationship in kidney disease progression, and the signaling proteins involved.”
![This immunofluorescence image shows a kidney cell, derived from the db/db (diabetic) mouse model. Filamentous actin, a part of the cytoskeleton, is stained red to show the structure in the cell. Macrophages, or immune cells, are green. In diabetic kidney disease, macrophages will infiltrate the kidney, secreting proinflammatory proteins and a variety of elements that can cause damage over time.](/getmedia/91b65cf5-b796-4326-aeda-c3c0693d99f1/Fig-3B_11-08-2023-480x419.jpg)
During the study, db/db and healthy mice were given the supplement nicotinamide riboside, or NR. Also known as vitamin B3, NR is a precursor to the biologically functional form of nicotinamide adenine nucleotide, or NAD+, and can increase its levels within the body. A critical co-enzyme in metabolic processes, NAD+ is ubiquitous to every cell type, where it is essential to mitochondria metabolism and generating cellular energy.
The body naturally produces NAD+. With age, levels decline naturally, and low NAD+ also occurs with conditions such as diabetes, cardiovascular disease and neurological disorders.
“The etiology of kidney disease between diabetes and aging are very different,” Myakala said. “Diabetes is usually a higher-grade kidney disease compared to age alone.”
Inflammation is closely associated with damage to the mitochondria, and diabetic kidney disease. Giving NR to the db/db mice reduced inflammation and prevented many of the usual manifestations of kidney decline, for example, levels of blood-protein markers that rise in DKD progression were reduced after NR treatment.
This research helps demonstrate the importance of mitochondrial function in renal disease, particularly in diabetes. Researchers still do not fully understand the mechanisms that link mitochondria and inflammatory disease, and they require further study. This research provides insight, however, into the potential of using supplemental NR to improve mitochondrial function and gives hope for DKD treatment.
Myakala describes his dedication to understanding the mechanisms of kidney disease as “unwavering.” He and his colleagues hope to continue their research as they seek to bridge the gap in understanding that exists between inflammation, mitochondria and kidney disease.
Enjoy reading ASBMB Today?
Become a member to receive the print edition monthly and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
![Radioactive drugs strike cancer with precision](/getmedia/f3a6418b-340a-43cc-b53f-30916dbbd8f4/Radioactive-drugs-strike-cancer-480x270.jpg?width=480&height=270&ext=.jpg)
Radioactive drugs strike cancer with precision
The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.
![Animals have used bioluminescence to communicate for millions of years](/getmedia/ea1a59f2-95d0-4ea4-93e9-e62dd77b3936/Glowing-corals-480x270.jpg?width=480&height=270&ext=.jpg)
Animals have used bioluminescence to communicate for millions of years
Despite its widespread occurrence, scientists don’t yet know when or where this phenomenon first emerged, or its original function.
![Getting to the genetic basis of cardiovascular disease](/getmedia/650199da-40a0-466d-a7e0-6ef53d27c1a4/Tabor-Award-Martinez-480x270.jpg?width=480&height=270&ext=.jpg)
Getting to the genetic basis of cardiovascular disease
Edwin G. Peña Martínez received a JBC Tabor award for associating the condition with mutations in noncoding sequences.
![Microparticles safeguard vitamins and information](/getmedia/d86107e4-f7f5-4117-8245-a74963d622ed/Jaklenec-thumb-480-x-270-px.jpg?width=480&height=270&ext=.jpg)
Microparticles safeguard vitamins and information
Scientists aim to use nanotechnology to combat malnutrition and improve medical recordkeeping in impoverished parts of the world.
![Why AlphaFold 3 needs to be open source](/getmedia/ab85df91-ecc3-47ad-8c9f-3a564460bb88/AlphaFold-3-480x270.jpg?width=480&height=270&ext=.jpg)
Why AlphaFold 3 needs to be open source
The powerful AI-driven software from DeepMind was released without making its code openly available to scientists.
![Summertime can be germy](/getmedia/54fb702a-3add-4c5e-842b-cb60a51682b5/Summertime-can-be-germy-480x270.jpg?width=480&height=270&ext=.jpg)
Summertime can be germy
A microbiologist explains how to avoid getting sick at the barbecue, in the pool or on the trail.